For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
LPI (LP Information)' newest research report, the "Gastrointestinal OTC Drugs Industry Forecast" looks at past sales and reviews total world Gastrointestinal OTC Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Gastrointestinal OTC Drugs sales for 2023 through 2029. With Gastrointestinal OTC Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal OTC Drugs industry.
This Insight Report provides a comprehensive analysis of the global Gastrointestinal OTC Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastrointestinal OTC Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Gastrointestinal OTC Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal OTC Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal OTC Drugs.
The global Gastrointestinal OTC Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gastrointestinal OTC Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gastrointestinal OTC Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gastrointestinal OTC Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gastrointestinal OTC Drugs players cover GlaxoSmithKline, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi and Teva Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal OTC Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Laxatives
- Anti-Flatulents
- H2-Antaginists
- Anti-Diarrheals
- PPIs
- Anti-Emetics
- Other
Segmentation by application
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- GlaxoSmithKline
- Pfizer
- Johnson & Johnson
- Bayer
- Procter & Gamble
- Perrigo
- Abbott
- Sanofi
- Teva Pharmaceutical
- Nestle
- Boehringer Ingelheim
- Reckitt Benckiser
- Purdue Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Gastrointestinal OTC Drugs market?
What factors are driving Gastrointestinal OTC Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gastrointestinal OTC Drugs market opportunities vary by end market size?
How does Gastrointestinal OTC Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?